[go: up one dir, main page]

EA200600158A1 - Связывающиеся с эмиттером пептиды, которые вызывают изменение спектральных характеристик эмиссии эмиттера - Google Patents

Связывающиеся с эмиттером пептиды, которые вызывают изменение спектральных характеристик эмиссии эмиттера

Info

Publication number
EA200600158A1
EA200600158A1 EA200600158A EA200600158A EA200600158A1 EA 200600158 A1 EA200600158 A1 EA 200600158A1 EA 200600158 A EA200600158 A EA 200600158A EA 200600158 A EA200600158 A EA 200600158A EA 200600158 A1 EA200600158 A1 EA 200600158A1
Authority
EA
Eurasian Patent Office
Prior art keywords
emitter
peptides
cause
change
spectral characteristics
Prior art date
Application number
EA200600158A
Other languages
English (en)
Other versions
EA010289B1 (ru
Inventor
Михаэль Ширнер
Кай Лиха
Андреас Менрад
Штефания Урлингер
Корнелия Ханель
Бодо Брокс
Original Assignee
Шеринг Акциенгезельшафт
Морфозис Аг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2003131054 external-priority patent/DE10331054A1/de
Application filed by Шеринг Акциенгезельшафт, Морфозис Аг filed Critical Шеринг Акциенгезельшафт
Publication of EA200600158A1 publication Critical patent/EA200600158A1/ru
Publication of EA010289B1 publication Critical patent/EA010289B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

В заявке описаны связывающиеся с эмиттером пептиды, которые вызывают изменение спектральных характеристик эмиссии эмиттера при взаимодействии их антигенсвязывающего «кармана» с эмиттером. Связывающиеся с эмиттером пептиды представляют прежде всего компоненты антитела и фрагменты антител.
EA200600158A 2003-07-09 2004-07-09 Связывающиеся с эмиттером пептиды, которые вызывают изменение спектральных характеристик эмиссии эмиттера EA010289B1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE2003131054 DE10331054A1 (de) 2003-07-09 2003-07-09 Emitter-bindende Peptide die eine Veränderung der spektralen Emissionseigenschaften des Emitters bewirken
US48723403P 2003-07-16 2003-07-16
PCT/EP2004/007596 WO2005005483A1 (de) 2003-07-09 2004-07-09 Emitter-bindende peptide, die eine veränderung der spektralen emissionseigenschaften des emitters bewirken

Publications (2)

Publication Number Publication Date
EA200600158A1 true EA200600158A1 (ru) 2006-08-25
EA010289B1 EA010289B1 (ru) 2008-08-29

Family

ID=34066308

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200600158A EA010289B1 (ru) 2003-07-09 2004-07-09 Связывающиеся с эмиттером пептиды, которые вызывают изменение спектральных характеристик эмиссии эмиттера

Country Status (13)

Country Link
US (1) US20050064512A1 (ru)
EP (2) EP1641829A1 (ru)
JP (1) JP2007526750A (ru)
KR (1) KR20060067949A (ru)
AT (1) ATE470678T1 (ru)
AU (1) AU2004255358A1 (ru)
BR (1) BRPI0412374A (ru)
CA (1) CA2531962A1 (ru)
DE (1) DE502004011269D1 (ru)
EA (1) EA010289B1 (ru)
HK (1) HK1094209A1 (ru)
IL (1) IL172548A0 (ru)
WO (2) WO2005005482A1 (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008092041A2 (en) 2007-01-24 2008-07-31 Carnegie Mellon University Optical biosensors
US8426153B2 (en) * 2007-12-03 2013-04-23 Carnegie Mellon University Linked peptides fluorogenic biosensors
KR101335560B1 (ko) * 2009-11-19 2013-12-31 우시오덴키 가부시키가이샤 형광 면역 측정 방법
CN102993305B (zh) * 2012-11-16 2015-05-13 上海赛伦生物技术有限公司 人源抗人表皮生长因子受体抗体及其编码基因与应用
US9862682B2 (en) 2016-01-08 2018-01-09 BroadPharm Functionalized pegylated cyanine compounds, pharmaceutical compositions, and methods of use thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4837003A (en) * 1984-09-13 1989-06-06 Mallinckrodt, Inc. Radiolabeled antibody fragments
US5569587A (en) * 1986-04-18 1996-10-29 Carnegie Mellon University Method for labeling and detecting materials employing luminescent arysulfonate cyanine dyes
US5268486A (en) * 1986-04-18 1993-12-07 Carnegie-Mellon Unversity Method for labeling and detecting materials employing arylsulfonate cyanine dyes
US6492160B1 (en) * 1991-05-15 2002-12-10 Cambridge Antibody Technology Limited Methods for producing members of specific binding pairs
JPH07501451A (ja) * 1991-11-25 1995-02-16 エンゾン・インコーポレイテッド 多価抗原結合タンパク質
US6437099B1 (en) * 1998-01-07 2002-08-20 Hamamatsu Photonics K.K. Fluorescene—activating antisera and IgG fraction therefrom
WO2002022629A1 (en) * 2000-09-13 2002-03-21 The Scripps Research Institute Anti-stilbene antibodies
EP1550871B1 (en) * 2002-09-19 2009-08-12 Hamamatsu Photonics K. K. Fluorescence analysis method with the use of fluorescent antibody

Also Published As

Publication number Publication date
ATE470678T1 (de) 2010-06-15
EP1641829A1 (de) 2006-04-05
WO2005005483A1 (de) 2005-01-20
WO2005005482A1 (de) 2005-01-20
US20050064512A1 (en) 2005-03-24
EA010289B1 (ru) 2008-08-29
JP2007526750A (ja) 2007-09-20
CA2531962A1 (en) 2005-01-20
BRPI0412374A (pt) 2006-09-05
HK1094209A1 (en) 2007-03-23
AU2004255358A1 (en) 2005-01-20
EP1641830B1 (de) 2010-06-09
DE502004011269D1 (de) 2010-07-22
IL172548A0 (en) 2006-04-10
KR20060067949A (ko) 2006-06-20
EP1641830A1 (de) 2006-04-05

Similar Documents

Publication Publication Date Title
CR9599A (es) Proteinas de union a il-12/p40
ES2527961T3 (es) Anticuerpos monoclonales humanos para CD70
NO2017032I1 (no) bezlotoksumab
PL1699822T3 (pl) Białka fuzyjne IL-7 z częściami przeciwciała, ich otrzymywanie oraz ich zastosowanie
CY1116913T1 (el) Τροποποιημενα κλασματα fab αντισωματων
EA200702008A1 (ru) Антитела-нейтрализаторы гранулоцитарно-макрофагального колониестимулирующего фактора человека
HRP20050354B1 (ru)
TR201901841T4 (tr) Her antikorlarının sabit dozlaması.
IS8026A (is) Mótefni gegn amýlóíðum, samsetningar, aðferðir ognotkun
EA201100868A1 (ru) Противоопухолевые комбинации, содержащие антитела, специфически распознающие cd38, и цитарабин
EP1620456A4 (en) Hla-a2 tumor associated antigen peptides and compositions
EA200870130A1 (ru) Антитела против ил-6, предотвращающие связывание с gp130 комплекса ил-6 и альфа-рецептора ил-6
EA201100869A1 (ru) Противоопухолевые комбинации, содержащие специфически распознающие cd38 антитела и циклофосфамид
EA200702643A1 (ru) Антитела, связывающие tweak
ES2639026T3 (es) Anticuerpos totalmente humanos específicos para CADM1
ATE473279T1 (de) In metastatischen menschlichen tumorzellen exprimiertes glycoproteinantigen sima135
ATE395082T1 (de) Antikörper gegen krebsantigen tmeff2 und seine anwendungen
HK1074670A1 (en) Sets of digital antibodies directed against short epitopes, and methods using same
HK1094209A1 (en) Emitter-binding peptides that produce a change in the spectral emission properties of the emitter
UA98100C2 (ru) Гуманизированное моноклональное антитело, которое связывается с человеческим nogo и нейтрализует его
BR8201394Y1 (pt) planador com atiradeira.
EA200401034A1 (ru) Цитопротекторный комплекс
HN2002000177A (es) 2-tio-3,5-diciano-4-fenil-6-aminopiridinas substituidas y su uso.
ES1054977U (es) Moño postizo compacto y acoplado
RU2003115161A (ru) Теплостроительный материал "торфолит"

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ KZ KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): BY RU